Result Update. Atul Auto. Accumulate

Similar documents
Result Update. Sterling Tools. Buy

Result Update. Sterling Tools. Accumulate

Result Update. Ahluwalia Contracts. Buy

Result Update. Havells. Buy

MRF. Result Update. Accumulate

Result Update. Skipper. Sell

Result Update. Khadim India. Buy

Result Update. Tech Mahindra. Buy

CONCOR. Management Meeting Update. Buy

Infosys. Result Update. Buy

Bharat Petroleum Corporation

Result Update ITC. Accumulate

Result Update. KEI Industries. Buy

Techno Electric & Engineering

Maruti Suzuki India. Result Update. Accumulate. Product mix driving margins

MRF. Result Update. Accumulate

Skipper. Result Update. Reduce

Transport Corporation of India

Maruti Suzuki India. Result Update. Accumulate. Growth Story Continues. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Result Update. NIIT Technologies. Buy

Voltas. Result Update. Buy. Q4FY18 Result (` Mn) May 21, 2018

Berger Paints. Result Update. Downgrade to Reduce (Prev. - Accumulate) Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 06, 2017

GSK Pharma. Result Update. Buy

HCC. Result Update. Accumulate. Debt reduction factored in. Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 03, 2017

Music Broadcast. Result Update. Buy. Valuation (x) Estimates (` Mn) Q1FY18 Result (` Mn)

INOX Leisure. Result Update. Accumulate. Valuation (x) Estimates (` Mn) Q4FY18 Result (` Mn) May 08, 2018

NCC. Result Update. Accumulate

Larsen & Toubro. Result Update. Accumulate. Valuation (x) Estimates (` Bn) Q1FY18 Result (` Mn) July 26, 2018

Simplex Infrastructures

Gujarat State Petronet

Balkrishna Industries

Shemaroo Entertainment

Transport Corporation of India

Q3FY19 Quarterly Preview IT Services

Dilip Buildcon. Result Update. Buy. Stellar performance continues

Skipper. Buy. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

Music Broadcast. Annual Report Analysis. Buy. Financials (` mn) August 31, 2018

Container Corporation of India

Kajaria Ceramics. Result Update. Buy

Skipper. Accumulate. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

Mahanagar Gas. Result Update. Accumulate

ICICI Bank. Result Update. Buy. Mixed bag. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Result Update. HDFC Bank. Accumulate

Page Industries. Annual Report Analysis. Accumulate. FINANCIALS (` Mn) July 14, 2017

Dixon Technologies. Annual Report Analysis. Accumulate. Annual Report The IPO year. FINANCIALS (` Mn)

Particulars Q3FY15 Q3FY14 YoY (%) Q2FY15 QoQ (%) 9MFY15 9MFY14 YoY (%) Net Sales 3,774 3, , ,453 8,

Kalpataru Power Transmission

Sagar Cement. Result Update. Buy. Valuation (x) Estimates (` mn) Q1FY19 Result (` Mn)

Result Update. Yes Bank. Buy

Dilip Buildcon. Visit Note. Buy. FY18E a bumper year! Show continues!

Repco Home Finance REPCO IN

ICICI Bank. Result Update. Buy

JK Cement. Result Update. Buy. Q3FY18 Result (` Mn)

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Near-term pressure, but long-term outlook positive

Cummins India Ltd Bloomberg Code: KKC IN

Visaka Industries Ltd

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Bloomberg Code: ATA IN

Symphony Ltd. RESULT UPDATE 31st October 2017

Fineotex Chemical Ltd

Ahluwalia Contracts (India)

TVS Motors. Source: Company Data; PL Research

KEC International. Annual Report Analysis. Accumulate

Still on track. Exhibit 1: ICT is on track for FY09E

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

BLS International Services

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Maruti Suzuki. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research

Hindustan Unilever (RHS)

Coal India. Source: Company Data; PL Research

Healty cigarette-driven growth

Century Plyboards (I) Limited

Cummins India. Source: Company Data; PL Research

Simplex Infrastructures

Sanofi India. Company Update. Buy

Multi Commodity Exchange

Bayer Cropscience (BYRCS IN)

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

ITC Ltd. RESULT UPDATE 27th October, 2017

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

Gulf Oil Lubricants BUY RESULTS REVIEW 1QFY19 09 AUG Key highlights

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Britannia Industries

Navin Fluorine International

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x

Asian Paints. Source: Company Data; PL Research

Q3FY13 Q3FY12 YOY(%) Q2FY13

Coal India. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Crompton Greaves Consumer Electricals

Bharat Forge Ltd RESULT UPDATE

Asian Paints. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Transcription:

Atul Auto Accumulate Result Update Looking out for margin and distribution expansion Atul Auto (ATA) top line growth was in-line with our estimates at ` 1,765 mn but margins were lower due to higher other expenditure. ATA reported volume growth of 9.5% at 12,224 units which were largely driven by higher exports. Domestic volumes grew by 4.4% YoY whereas the exports reported a growth of 76% YoY in. ATA also declared an interim dividend of ` 2.75. Going forward, we believe that ATA volume growth can improve only if distribution reach is further expanded. Existing areas will offer limited growth despite addition of new products. ATA has been investing in electric autos, but a meaningful scale will depend on evolvement of whole ecosystem mainly charging points and battery cost. We retain our Accumulate rating with a target price of ` 396. Passenger Carrier performance remains strong Total volume for the quarter increased by 9.4% YoY. Passenger carrier forms ~64% of the total volume sales for the quarter and grew by 22.4% YoY as compared to de-growth of 7.8% YoY in goods carrier segment. We believe that a major chunk of this growth was due to ongoing distribution channel expansion. ATA has applied for approvals for selling its passenger carrier in various states and volumes will expand as and when this approval comes. Revival in the goods segment will depend on product launches as competition is ahead with continuous addition of new products. Valuation With pending approvals from few states in India and expansion in export business, volume growth should sustain in low double digits. ATA gained volume growth of 13% YoY in 1HFY19. However, higher raw material cost has been weighing heavily on the gross margin. Realizations for ATA have been almost flat for 1HFY19 (.5% increase). Further price increase and better operating mix will be the key thing to watch going forward. Underperformance to the industry weighs down on valuations. Maintain Accumulate with a target price of ` 396. Result (` Mn) Particulars YoY (%) QoQ (%) Revenue 1,765 1,599 1.4 1,373 28.5 Total Expense 1,536 1,329 15.5 1,2.4 EBITDA 229 269 (14.9) 148 54.4 Depreciation 14 13 5.3 13 3. EBIT 215 6 (15.9) 135 59.6 Other Income 22 5 313.5 24 (11.5) Interest 4 1 457.1 2 116.7 EBT 233 261 (15.9) 158 47.9 Tax 84 91 (7.9) 54 54. RPAT 149 17 (12.1) 13 44.7 APAT 149 17 (12.1) 13 44.7 (bps) (bps) Gross Margin (%).2 28.1 (287).9 (68) EBITDA Margin (%) 13. 16.8 (386) 1.8 218 NPM (%) 8.5 1.6 (216) 7.5 95 Tax Rate (%) 36. 34.9 16 34.5 143 EBIT Margin (%) 12.2 16. (382) 9.8 237 CMP ` 359 Target / Upside ` 396 / 1% BSE Sensex 35,12 NSE Nifty 1,553 Scrip Details Equity / FV ` 11mn / ` 5 Market Cap ` 8bn US$ 19mn 52-week High/Low ` 476/` 269 Avg. Volume (no) 2,56 NSE Symbol Bloomberg Code ATULAUTO Shareholding Pattern Sep'18(%) ATA IN Promoters 52.7 MF/Banks/FIs 18.4 FIIs.2 Public / Others 28.7 Valuation (x) FY18A FY19E FY2E P/E 17.1 15. 12.7 EV/EBITDA 1. 8.4 7. ROE (%) 22.9 22.2 22.7 RoACE (%) 21.6 2.5 2.8 Estimates (` mn) FY18A FY19E FY2E Revenue 5,56 6,339 7,24 EBITDA 7 822 959 PAT 462 526 621 EPS (`) 21.1 24. 28.3 VP Research: Priyank Chandra Tel: +91 22 4969737 E-mail: priyank@dolatcapital.com Associate: Kushal Shah Tel: +91 22 4969768 E-mail: kushals@dolatcapital.com November 5, 218

Net Sales (` in Mn) EBITDA (` in Mn) 2, 1,75 1,5 1, 1, 75 5 1,59 1,418 1,512 1,291 9 1,427 1,338 1,33 1,155 1,589 1,279 1,489 1,361 1,752 3 2 15 1 5 119 1 219 173 87 22 189 12 12 269 156 181 148 229 Net profit (` in Mn) Gross Margin % 2 175 15 1 1 75 5 71 16 135 19 5 138 123 64 78 17 149 117 97 13 29 28 27 26 24 26.6 28.4 27.9 26.9 28.4 28.1 27.5 28.1 26. 24.4 27.9 26.9.9.2 OPM % Net Profit Margin (%) 18 16 14 12 1 8 11.1 16.6 15.3 13.4 15.3 9.4 14. 9.8 1.3 16.8 13. 12.1 12. 1.8 11 1 9 8 7 6 5 4 9.4 6.7 1.5 9.6 9.1 8.4 6.1 5.4 6.7 1.6 8.5 7.5 7.8 7.5 November 5, 218 2

Volumes and Realisations Gross Spread and Gross Margin 14, 13, 12, 11, 1, 9, 8, 7, 6, 135 13 1 12 115 11 37 35 33 31 29 27 29 28 27 26 24 Volume (LHS) Realisations / Unit (` in ') RHS Gross Profit / Unit (` in ') - LHS Gross Margin (RHS) EBIDTA Spread and EBIDTA Margin 18 2 16 15 14 1 12 5 1 8 EBITDA / Unit (` in ') - RHS EBITDA Margin November 5, 218 3

Profit and Loss Account (` Mn) FY17A FY18A FY19E FY2E Revenue 4,753 5,56 6,339 7,24 Total Expense 4,158 4,834 5,517 6,244 COGS 3,457 4,42 4,645 5,272 Employees Cost 392 41 441 494 Other expenses 39 391 43 477 EBIDTA 595 7 822 959 Depreciation 53 53 57 65 EBIT 542 673 765 894 Interest 6 4 6 6 Other Income 26 51 67 EBT 561 694 81 955 Tax 191 232 283 334 RPAT 37 462 526 621 APAT 37 462 526 621 Balance Sheet (` Mn) FY17A FY18A FY19E FY2E Sources of Funds Equity Capital 11 11 11 11 Reserves & Surplus 1,733 2,84 2,431 2,821 Net Worth 1,842 2,194 2,541 2,931 Net Deferred Tax Liability 52 53 61 71 Total Capital Employed 1,894 2,247 2,62 3,1 Applications of Funds Net Block 862 86 953 1,38 CWIP 32 53 54 55 Investments 88 137 191 171 Current Assets, Loans & Advances 1,472 1,943 2,24 2,673 Inventories 362 46 516 589 Receivables 472 782 76 824 Cash and Bank Balances 4 179 556 784 Loans and Advances 1 1 1 1 Other Current Assets 53 67 6 55 Less: Current Liabilities & Provisions 559 746 835 936 Payables 36 494 59 691 Other Current Liabilities 199 2 245 245 Net Current Assets 913 1,197 1,44 1,737 Total Assets 1,894 2,247 2,62 3,1 E Estimates November 5, 218 4

Important Ratios Particulars FY17A FY18A FY19E FY2E (A) Margins (%) Gross Profit Margin 27.3 27.3 26.7 26.8 EBIDTA Margin 12.5 13. 13. 13.3 EBIT Margin 11.4 12.1 12.1 12.4 Tax rate 34. 33.5 35. 35. Net Profit Margin 7.8 8.3 8.3 8.6 (B) As Percentage of Net Sales (%) COGS 72.7 72.7 73.3 73.2 Employee 8.2 7.2 7. 6.9 Other 6.5 7. 6.8 6.6 (C) Measure of Financial Status Interest Coverage 93.5 159.6 123.4 151.6 Inventory days 28 3 3 3 Debtors days 36 51 41 42 Payable days 28 32 34 35 Working Capital days 7 79 81 88 FA T/O 5.5 6.5 6.6 6.9 (D) Measures of Investment AEPS (`) 16.9 21.1 24. 28.3 CEPS (`) 19.3 23.4 26.6 31.3 DPS (`) 4.3 5.3 7. 9. Dividend Payout (%).2 24.9 29.2 31.8 BVPS (`) 84. 1. 115.8 133.6 RoANW (%) 21.9 22.9 22.2 22.7 RoACE (%) 2.5 21.6 2.5 2.8 RoAIC (%) 36.9 38. 37.2 42. (E) Valuation Ratios CMP (`) 359 359 359 359 P/E 21.3 17.1 15. 12.7 Mcap (` Mn) 7,884 7,884 7,884 7,884 MCap/ Sales 1.7 1.4 1.3 1.1 EV 7,3 7,2 6,928 6,681 EV/Sales 1.5 1.3 1.1.9 EV/EBITDA 12.3 1. 8.4 7. P/BV 4.3 3.6 3.1 2.7 Dividend Yield (%) 1.2 1.5 1.9 2.5 (F) Growth Rate (%) Revenue (1.5) 17. 14. 13.6 EBITDA (22.) 21.9 13.3 16.7 EBIT (23.6) 24.1 13.7 16.9 PBT (21.6) 23.8 16.7 17.9 APAT (21.8) 24.7 14. 17.9 EPS (21.8) 24.7 14. 17.9 Cash Flow (` Mn) FY17A FY18A FY19E FY2E CFO 711 261 715 615 CFI (29) (392) (151) (151) CFF (139) (112) (186) (237) FCFF 637 189 564 464 Opening Cash 128 4 179 556 Closing Cash 4 179 556 784 E Estimates November 5, 218 5

May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 DART RATING MATRIX Total Return Expectation (12 Months) Buy > 2% Accumulate 1 to 2% Reduce to 1% Sell < % Rating and Target Price History 51 46 (`) ATA Target Price Month Rating TP (`) Price (`)* Feb-18 Accumulate 459 413 May-18 Accumulate 476 433 Aug-18 Accumulate 456 49 41 36 31 26 * Price as on Recommendation Date DART Team Purvag Shah Managing Director purvag@dolatcapital.com +9122 496 9747 Amit Khurana, CFA Head of Equities amit@dolatcapital.com +9122 496 9745 CONTACT DETAILS Equity Sales Designation E-mail Direct Lines Dinesh Bajaj VP - Equity Sales dineshb@dolatcapital.com +9122 496 979 Kartik Sadagopan VP - Equity Sales kartiks@dolatcapital.com +9122 496 9762 Kapil Yadav VP - Equity Sales kapil@dolatcapital.com +9122 496 9735 Equity Trading Designation E-mail P. Sridhar SVP and Head of Sales Trading sridhar@dolatcapital.com +9122 496 9728 Chandrakant Ware VP - Sales Trading chandrakant@dolatcapital.com +9122 496 977 Shirish Thakkar VP - Head Domestic Derivatives Sales Trading shirisht@dolatcapital.com +9122 496 972 Kartik Mehta VP - Head Asia Derivatives Sales Trading kartikm@dolatcapital.com +9122 496 9715 Bhavin Mehta VP - Derivatives Strategist bhavinm@dolatcapital.com +9122 496 975 Hardik Mehta Sales Trader hardikm@dolatcapital.com +9122 496 973 Dolat Capital Market Private Limited. Sunshine Tower, 28th Floor, Senapati Bapat Marg, Dadar (West), Mumbai 413

Analyst(s) Certification The research analyst(s), with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this research report. I. Analyst(s) and Associate (S) holding in the Stock(s): (Nil) II. Disclaimer: This research report has been prepared by Dolat Capital Market Private Limited. to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies) solely for the purpose of information of the select recipient of this report. This report and/or any part thereof, may not be duplicated in any form and/or reproduced or redistributed without the prior written consent of Dolat Capital Market Private Limited. This report has been prepared independent of the companies covered herein. Dolat Capital Market Private Limited. and its affiliated companies are part of a multi-service, integrated investment banking, brokerage and financing group. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have provided or may provide services in respect of managing offerings of securities, corporate finance, investment banking, mergers & acquisitions, financing or any other advisory services to the company(ies) covered herein. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have received or may receive compensation from the company(ies) mentioned in this report for rendering any of the above services. Research analysts and sales persons of Dolat Capital Market Private Limited. may provide important inputs to its affiliated company(ies) associated with it. While reasonable care has been taken in the preparation of this report, it does not purport to be a complete description of the securities, markets or developments referred to herein, and Dolat Capital Market Private Limited. does not warrant its accuracy or completeness. Dolat Capital Market Private Limited. may not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. This report is provided for information only and is not an investment advice and must not alone be taken as the basis for an investment decision. The investment discussed or views expressed herein may not be suitable for all investors. The user assumes the entire risk of any use made of this information. The information contained herein may be changed without notice and Dolat Capital Market Private Limited. reserves the right to make modifications and alterations to this statement as they may deem fit from time to time. Dolat Capital Market Private Limited. and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. This report is neither an offer nor solicitation of an offer to buy and/or sell any securities mentioned herein and/or not an official confirmation of any transaction. This report is not directed or intended for distribution to, or use by any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Dolat Capital Market Private Limited. and/or its affiliated company(ies) to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession this report may come, are required to inform themselves of and to observe such restrictions. For U.S. Entity/ persons only: This research report is a product of Dolat Capital Market Private Limited., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Dolat Capital Market Private Limited. only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person or entity. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Dolat Capital Market Private Limited. has entered into an agreement with a U.S. registered brokerdealer Ltd Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer/entity as informed by Dolat Capital Market Private Limited. from time to time. Dolat Capital Market Private Limited. Corporate Identity Number: U6599DD1993PTC9797 Member: BSE Limited and National Stock Exchange of India Limited. SEBI Registration No: BSE - INB17152 & INF17152, NSE - INB237131& INF237131, Research: INH685 Registered office: Office No. 141, Centre Point, Somnath, Daman 396 21, Daman & Diu Board: +9122 49697 Fax: +9122 22651278 Email: research@dolatcapital.com www.dolatcapital.com Our Research reports are also available on Reuters, Thomson Publishers, DowJones and Bloomberg (DCML <GO>)